Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedele, M.
Right arrow Articles by Fusco, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fedele, M.
Right arrow Articles by Fusco, A.
[Cancer Research 66, 2536-2543, March 1, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice

Monica Fedele1,8, Vincenzo Fidanza8, Sabrina Battista1,8, Francesca Pentimalli1,8, Andres J.P. Klein-Szanto9, Rosa Visone1, Ivana De Martino1, Antonio Curcio6, Carmine Morisco2, Luigi Del Vecchio3, Gustavo Baldassarre8, Claudio Arra4, Giuseppe Viglietto1, Ciro Indolfi6, Carlo M. Croce7 and Alfredo Fusco1,5

1 Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare and 2 Division of Cardiology, Università di Napoli "Federico II"; 3 Servizio di Immunoematologia e Medicina Trasfusionale, Ospedale A. Cardarelli; 4 Istituto dei Tumori di Napoli; 5 Naples Oncogenomic Center, CEINGE Biotecnologie Avanzate and European School of Molecular Medicine (Naples Site), Naples, Italy; 6 Division of Cardiology, Università di Catanzaro, Catanzaro, Italy; 7 Division of Human Cancer Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; 8 Kimmel Cancer Center, Jefferson Medical College; 9 Experimental Histopathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Requests for reprints: Alfredo Fusco, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, via S. Pansini 5, 80131 Naples, Italy. Phone: 39-81-746-3056; Fax: 39-81-746-3037; E-mail: afusco{at}napoli.com.

The HMGA1 protein is a major factor in chromatin architecture and gene control. It plays a critical role in neoplastic transformation. In fact, blockage of HMGA1 synthesis prevents rat thyroid cell transformation by murine transforming retroviruses, and an adenovirus carrying the HMGA1 gene in the antisense orientation induces apoptotic cell death in anaplastic human thyroid carcinoma cell lines, but not in normal thyroid cells. Moreover, both in vitro and in vivo studies have established the oncogenic role of the HMGA1 gene. In this study, to define HMGA1 function in vivo, we examined the consequences of disrupting the Hmga1 gene in mice. Both heterozygous and homozygous mice for the Hmga1-null allele show cardiac hypertrophy due to the direct role of HMGA1 on cardiomyocytic cell growth regulation. These mice also developed hematologic malignancies, including B cell lymphoma and myeloid granuloerythroblastic leukemia. The B cell expansion and the increased expression of the RAG1/2 endonuclease, observed in HMGA1-knockout spleen tissues, might be responsible for the high rate of abnormal IgH rearrangements observed in these neoplasias. Therefore, the data reported here indicate the critical role of HMGA1 in heart development and growth, and reveal an unsuspected antioncogenic potential for this gene in hematologic malignancies. (Cancer Res 2006; 66(5): 2536-43)




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Pallante, A. Federico, M. T. Berlingieri, M. Bianco, A. Ferraro, F. Forzati, A. Iaccarino, M. Russo, G. M. Pierantoni, V. Leone, et al.
Loss of the CBX7 Gene Expression Correlates with a Highly Malignant Phenotype in Thyroid Cancer
Cancer Res., August 15, 2008; 68(16): 6770 - 6778.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
I. De Martino, R. Visone, D. Palmieri, P. Cappabianca, P. Chieffi, F. Forzati, A. Barbieri, M. Kruhoffer, G. Lombardi, A. Fusco, et al.
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas
Endocr. Relat. Cancer, September 1, 2007; 14(3): 875 - 886.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Cattaruzzi, S. Altamura, M. A. Tessari, A. Rustighi, V. Giancotti, C. Pucillo, and G. Manfioletti
The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and function
Nucleic Acids Res., March 19, 2007; 35(6): 1751 - 1760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.